Evidence map›Paper›PMID 23639809›Full record

ArticleAmerican journal of physiology. Gastrointestinal and liver physiology2013

Gastroesophageal reflux activates the NF-κB pathway and impairs esophageal barrier function in mice.

Yu Fang, Hao Chen, Yuhui Hu, Zorka Djukic, Whitney Tevebaugh, Nicholas J Shaheen, Roy C Orlando, Jianguo Hu, Xiaoxin Chen

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Gastrointestinal and liver physiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Immune functions of the esophagus.The Journal of allergy and clinical immunology · 2026
    Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Yu FangDepartment of Cardiovascular and Thoracic Surgery, Second Xiangya Hospital, Central South University, Changsha, Hunan Province, China.
Hao Chen
Yuhui Hu
Zorka Djukic
Whitney Tevebaugh
Nicholas J Shaheen
Roy C Orlando
Jianguo Hu
Xiaoxin Chen
North Carolina Central University · USUniversity of North Carolina at Chapel Hill · USCentral South University · CN

Funding

Targeting the MEKK2-ERK5 Signaling Node in Triple Negative Breast CancerU54CA156735 · NCI · NORTH CAROLINA CENTRAL UNIVERSITY · PI RICHARDSON, MICHELER RICARDO · 2010 to 2021
$13.0M
Targeting the MEKK2-ERK5 Signaling Node in Triple Negative Breast CancerU54CA156733 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LINNAN, LAURA A · 2010 to 2020
$9.7M
NCI NIH HHS U54 CA156733NCI NIH HHS U54 CA-156735NCI NIH HHS U54 CA156735
6 · The paper itself

Abstract

The barrier function of the esophageal epithelium is a major defense against gastroesophageal reflux disease. Previous studies have shown that reflux damage is reflected in a decrease in transepithelial electrical resistance associated with tight junction alterations in the esophageal epithelium. To develop novel therapies, it is critical to understand the molecular mechanisms whereby contact with a refluxate impairs esophageal barrier function. In this study, surgical models of duodenal and mixed reflux were developed in mice. Mouse esophageal epithelium was analyzed by gene microarray. Gene set enrichment analysis showed upregulation of inflammation-related gene sets and the NF-κB pathway due to reflux. Significance analysis of microarrays revealed upregulation of NF-κB target genes. Overexpression of NF-κB subunits (p50 and p65) and NF-κB target genes (matrix metalloproteinases-3 and -9, IL-1β, IL-6, and IL-8) confirmed activation of the NF-κB pathway in the esophageal epithelium. In addition, real-time PCR, Western blotting, and immunohistochemical staining also showed downregulation and mislocalization of claudins-1 and -4. In a second animal experiment, treatment with an NF-κB inhibitor, BAY 11-7085 (20 mg·kg⁻¹·day⁻¹ ip for 10 days), counteracted the effects of duodenal and mixed reflux on epithelial resistance and NF-κB-regulated cytokines. We conclude that gastroesophageal reflux activates the NF-κB pathway and impairs esophageal barrier function in mice and that targeting the NF-κB pathway may strengthen esophageal barrier function against reflux.

Indexed as

AnimalsCytokinesEpitheliumEsophagusGastroesophageal RefluxGene Expression RegulationMatrix Metalloproteinase 3Matrix Metalloproteinase 9MiceMice, Inbred C57BLNF-kappa BNitrilesOligonucleotide Array Sequence AnalysisSulfonesBAY 11-7085CytokinesMatrix Metalloproteinase 3Matrix Metalloproteinase 9NF-kappa BNitrilesSulfonesbarrier functiongastroesophageal refluxmouse modelNF-κBtight junction

Identifiers

PMID23639809
PMCPMC3725692
OpenAlexW2140179442

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.